Open AccessAssociation of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]
Author(s) -
Monkgomotsi J Maseng,
Leabaneng Tawe,
Prisca K. Thami,
Kaelo K. Seatla,
Sikhulile Moyo,
Axel Martinelli,
Ishmael Kasvosve,
Vladimir Novitsky,
Max Essex,
Gianluca Russo,
Simani Gaseitsiwe,
Giacomo Maria Paganotti
Publication year - 2021
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s312741
Subject(s) - nevirapine , efavirenz , medicine , human immunodeficiency virus (hiv) , cyp2b6 , antiretroviral drug , virology , drug resistance , pharmacology , antiretroviral therapy , genetics , viral load , cyp3a4 , cytochrome p450 , metabolism , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom